Clinical Trial Update: RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance) [NA]

View source ↗

Summary

This is an update to the RECOVER-ENERGIZE platform protocol focusing on exercise intolerance in Long COVID, outlining study design and objectives.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Duke University | Conditions: Long COVID, Long Covid19 | NA | Status: ACTIVE_NOT_RECRUITING